Literature DB >> 23150443

Mutant p53 in cell adhesion and motility.

W Andrew Yeudall1, Katharine H Wrighton, Sumitra Deb.   

Abstract

Pro-oncogenic properties of mutant p53 were investigated with the aid of migration assays, adhesion assays, and soft agar growth assays using cells stably expressing gain-of-function p53 mutants. To determine cell migration, "wound-healing" (scratch) assays and haptotactic (chamber) assays were used. H1299 cells expressing mutant p53 were found to migrate more rapidly than cells transfected with empty vector alone. Results from both types of migration assay were broadly similar. Migratory ability differed for different p53 mutants, suggesting allele-specific effects. Cells expressing p53 mutants also showed enhanced adhesion to extracellular matrix compare to controls. Furthermore, stable transfection of mutant p53-H179L into NIH3T3 fibroblasts was sufficient to allow anchorage-independent growth in soft agar.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23150443     DOI: 10.1007/978-1-62703-236-0_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Fam83F induces p53 stabilisation and promotes its activity.

Authors:  Mohammed Salama; Diego Benitez-Riquelme; Seham Elabd; Leonel Munoz; Ping Zhang; Matthias Glanemann; Maria Caterina Mione; Robert Goldin; Thierry Soussi; Gary Davidson; Christine Blattner
Journal:  Cell Death Differ       Date:  2019-01-28       Impact factor: 15.828

2.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

3.  Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a "dominant-positive" mechanism.

Authors:  Dawid Walerych; Magdalena Pruszko; Lukasz Zyla; Michalina Wezyk; Katarzyna Gaweda-Walerych; Alicja Zylicz
Journal:  Oncotarget       Date:  2018-08-10

4.  Keratinocyte Motility Is Affected by UVA Radiation-A Comparison between Normal and Dysplastic Cells.

Authors:  Cristina M Niculiţe; Marina T Nechifor; Andreea O Urs; Laura Olariu; Laura C Ceafalan; Mircea Leabu
Journal:  Int J Mol Sci       Date:  2018-06-07       Impact factor: 5.923

Review 5.  Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer.

Authors:  Bryan E Strauss; Gissele Rolemberg Oliveira Silva; Igor de Luna Vieira; Otto Luiz Dutra Cerqueira; Paulo Roberto Del Valle; Ruan Felipe Vieira Medrano; Samir Andrade Mendonça
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

6.  Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.

Authors:  Shixing Wu; Bin Liu; Qingyu Zhang; Jie Liu; Wei Zhou; Chang Wang; Mingyi Li; Shiting Bao; Runzhi Zhu
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

7.  Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals.

Authors:  Jong-Gyu Lee; Ji-Hye Ahn; Tae Jin Kim; Jae Ho Lee; Jung-Hye Choi
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

8.  Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.

Authors:  Vikas Patil; Jagriti Pal; Kumaravel Somasundaram
Journal:  Oncotarget       Date:  2015-12-22

Review 9.  Molecular crosstalk between cancer and neurodegenerative diseases.

Authors:  Jiyeon Seo; Mikyoung Park
Journal:  Cell Mol Life Sci       Date:  2019-12-28       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.